AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

FEDERATED HERMES, INC.'s Holding History (CIK: 0001056288)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 457,412 Value ($000) $5,526 Avg Close $13.58 Range $11.69 - $16.96
Q3 2025
Shares 212,379 Value ($000) $2,886 Avg Close $9.41 Range $5.97 - $15.14
Q2 2025
Shares 203,930 Value ($000) $1,307 Avg Close $4.86 Range $3.11 - $6.70
Q1 2025
Shares 202,785 Value ($000) $718 Avg Close $3.56 Range $2.60 - $4.18
Q4 2024
Shares 202,316 Value ($000) $765 Avg Close $4.71 Range $2.91 - $7.27
Q3 2024
Shares 186,286 Value ($000) $604 Avg Close $2.25 Range $1.62 - $3.33
Q2 2024
Shares 178,774 Value ($000) $340 Avg Close $1.94 Range $1.57 - $2.89
Q1 2024
Shares 175,983 Value ($000) $500 Avg Close $13.08 Range $2.67 - $19.95
Q4 2023
Shares 102,500 Value ($000) $1,509 Avg Close $15.33 Range $11.82 - $18.88
Q3 2023
Shares 324,260 Value ($000) $5,937 Avg Close $21.15 Range $17.80 - $25.48
Q2 2023
Shares 1,529,000 Value ($000) $32,981 Avg Close $27.01 Range $20.79 - $31.77
Q1 2023
Shares 1,846,117 Value ($000) $54,165 Avg Close $34.74 Range $26.64 - $41.93
Q4 2022
Shares 1,614,845 Value ($000) $59,669 Avg Close $35.49 Range $28.13 - $39.77
Q3 2022
Shares 1,329,000 Value ($000) $37,411 Avg Close $24.95 Range $15.80 - $32.80